PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 1, 2011-01 ,pp. : 44-58

Bentham Science Publishers

Access to resources Recommend Favorite

Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol

By Sasaki H.   Hashimoto K.   Inada T.   Fukui S.   Iyo M.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 71-76

Elsevier

Access to resources Recommend Favorite

The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function

By Miller A.H.   Vogt G.J.   Pearce B.D.  

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 939-948

Elsevier

Access to resources Recommend Favorite

Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

By Siuciak Judith   Chapin Douglas   McCarthy Sheryl   Martin Ashley  

Psychopharmacology, Vol. 192, Iss. 3, 2007-06 ,pp. : 415-424

Springer Publishing Company

Access to resources Recommend Favorite

Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme

By Zhang H.-T.   Huang Y.   Jin S.-L.C.   Frith S.A.   Suvarna N.   Conti M.   O'Donnell J.M.  

Neuropsychopharmacology, Vol. 27, Iss. 4, 2002-10 ,pp. : 587-595

Elsevier

Access to resources Recommend Favorite